-
Jun 30, 06 FDA Approvals
The Food and Drug Administration (FDA) has approved Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia (chronic… »
Jun 30, 06 FDA ApprovalsDecision Resources, Inc., a research and advisory firm focusing on pharmaceutical and healthcare issues, finds that first-in-class targeted biologics will… »
Apr 15, 06 FDA ApprovalsFlonase Use
Flonase is an anti-inflammatory nasal spray that relieves nasal symptoms caused by seasonal allergies. Flonase reduces the… »
Apr 15, 06 Patent ExpirationThis is a sample entry. You can delete it from your Control Panel.
»
Subscribe to the "News" RSS Feed
TOP ۞